[{"uuid": "5cf95850-b511-33fa-a7f1-fca40310c449", "title": "Promising US Penny Stocks To Consider In January 2025", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/promising-us-penny-stocks-consider-201004884.html", "providerPublishTime": 1737749404, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6iRuoNg6exhoisM46ySxQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["SGHT", "ABOS", "VGZ"]}, {"uuid": "11a053b6-5b16-33fe-b94b-9feed3457dfe", "title": "Acumen announces Phase 1 INTERCEPT-AD study publication", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/acumen-announces-phase-1-intercept-130512062.html", "providerPublishTime": 1736514312, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JAkd0u.p7aqm9cNkwT3ICg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c7cc0ee97ba22ee31ce2f6fcf51d1f91", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/noN3BfKp3iIZZgFc7RdX4A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/c7cc0ee97ba22ee31ce2f6fcf51d1f91", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "24a02136-0150-3de8-8066-5d19407cce74", "title": "Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer\u2019s Disease Publication of the Company\u2019s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-announces-journal-prevention-130000510.html", "providerPublishTime": 1736427600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "f317d156-3966-3a8e-9563-7f43b18cf8fc", "title": "Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-inc-abos-q3-070637047.html", "providerPublishTime": 1731481597, "type": "STORY", "relatedTickers": ["ABOS"]}, {"uuid": "b5ccb1fc-7bcf-3b0a-8d34-79b72acdc0a9", "title": "Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-participate-7th-annual-210000227.html", "providerPublishTime": 1732654800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "3a75aa8a-06f5-355c-83c4-78f08602e518", "title": "Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-appoints-dr-amy-130000567.html", "providerPublishTime": 1730898000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "4521ce8a-1b22-3dcc-9602-5424c88ce00a", "title": "Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-reports-third-quarter-120000309.html", "providerPublishTime": 1731412800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "046aaeda-d06b-32de-9263-7ef22615dec7", "title": "Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-participate-stifel-healthcare-210000826.html", "providerPublishTime": 1731358800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "4c7f7056-7c98-31db-a712-2745634afe9d", "title": "Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/acumen-pharmaceuticals-participate-ubs-global-210000740.html", "providerPublishTime": 1730926800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KY.jMsT18Md4DR5gOMksgw--~B/aD0xMjQ7dz02MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 604, "height": 124, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1iLsTWE2QY4rw.MRmVn0aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/40438a97a5665a8ebefedee30f5e941c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABOS"]}, {"uuid": "29d73de3-dd1f-3047-9162-4ff013eec3f1", "title": "I-Mab Leads Our Spotlight On 3 US Penny Stocks", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/mab-leads-spotlight-3-us-130450737.html", "providerPublishTime": 1733317490, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PETS", "ABOS", "IMAB"]}, {"uuid": "11928e08-cfe4-3227-9c5d-325216aeb94f", "title": "Q3 2024 Acumen Pharmaceuticals Inc Earnings Call", "publisher": "Thomson Reuters StreetEvents", "link": "https://finance.yahoo.com/news/q3-2024-acumen-pharmaceuticals-inc-035447852.html", "providerPublishTime": 1731470087, "type": "STORY", "relatedTickers": ["ABOS"]}]